METHOD FOR SELECTING THERAPEUTIC APPROACH TO THYROID NODULES Russian patent published in 2024 - IPC A61B8/08 G01N33/48 G01T1/164 A61B17/00 

Abstract RU 2823767 C1

FIELD: medicine; surgery.

SUBSTANCE: complex laboratory-instrumental assessment of the risk of malignancy of thyroid nodules (TN) is carried out on the basis of an integral diagnostic scale on a five-point system from 0 to 4, where 0—absence, and 4—high risk of malignancy. Integral assessment of the results of modern methods of examining the thyroid nodules is carried out by calculating the sum of points of the developed scale. According to the results of thyroid ultrasound with stratification of malignancy risk depending on echographic characteristics according to the international classification system TIRADS: 0 points are assigned to TIRADS 2 category; 1 point—TIRADS 3; 2 points—TIRADS 4a; 3 points—TIRADS 4b and 4c; 4 points—TIRADS 5. When evaluating the results of the cytological examination of the material obtained by puncture fine-needle aspiration biopsy, with a description of the findings within the Bethesda system categories: 0 points is assigned to Bethesda I diagnostic category; 1—Bethesda II; 2—Bethesda IV; 3—Bethesda V; 4—Bethesda VI. Taking into account the technique of semi-quantitative evaluation of two-indicator scintigraphy data with 99mTc-pertechnetate and 99mTc-technetril with calculation of the wash-out index: 0 points is assigned if its value is >60%, 1—40–59.9%, 2—20–39.9%; 4—<20%. According to the results of assessing the level of expression of Galectin-3 and the presence of the V600E mutation of the BRAF gene in the puncture material: 0 points have SV with value Galectin-3 <20%, 1—20–39.9%, 2—40–59.9%, 3—60–80%, 4—>80%; detection of BRAF-mutation is evaluated as 4 points, its absence—1 point. Total score of the above laboratory-instrumental methods is calculated: from 0 to 5 points, the risk of malignancy is considered to be low and making 3–6.9%, from 6 to 10 points—medium and making 7–34.9%, from 11 to 15 points—increased and making 35–79.9%, from 16 to 20 points—high and making 80–96%. Derived data on the risk of thyroid nodules malignancy are used to justify the choice of therapeutic approach. In cases of low risk of malignancy in the absence of signs of neck compression, follow-up is recommended, if observing signs of neck compression, thyroid resection of various sizes is performed depending on involvement of lobes in the pathological process. In cases of average risk of malignancy of formations—performing organ-sparing operations in amount of hemithyroidectomy. In cases of increased risk of malignant growths—performing thyroidectomy with an individual solution to the issue of its addition with preventive central lymphadenectomy taking into account BRAF-status. In cases of high risk of malignancy of growths—radical extent of surgical intervention in amount of thyroidectomy with obligatory central lymphadenectomy.

EFFECT: method enables high-accuracy stratification of the risk of malignancy of thyroid nodules, to differentiate their nature and to substantiate the choice of rational tactics of treatment avoiding repeated surgical interventions and development of complications.

1 cl, 7 dwg, 2 tbl, 1 ex

Similar patents RU2823767C1

Title Year Author Number
DIAGNOSTIC TECHNIQUE FOR SURGICAL THYROID DISEASES USING DYNAMIC DOUBLE-INDICATOR SCINTIGRAPHY 2019
  • Romashchenko Pavel Nikolaevich
  • Majstrenko Nikolaj Anatolevich
  • Bojkov Igor Valerevich
  • Krivolapov Denis Sergeevich
  • Rozhnikova Natella Yanovna
  • Krotova Elena Vladimirovna
  • Talantov Sergej Vladimirovich
  • Vshivtsev Dmitrij Olegovich
RU2726601C1
METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS 2019
  • Durleshter Vladimir Moiseevich
  • Katanyan Gevork Artushovich
  • Titov Sergej Evgenevich
RU2705110C1
METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND 2022
  • Zima Dmitrij Vladimirovich
  • Bezrukov Oleg Filippovich
  • Zyablitskaya Evgeniya Yurevna
  • Golubinskaya Elena Petrovna
  • Makalish Tatyana Pavlovna
  • Maksimova Polina Evgenevna
  • Nepritimova Elena Andreevna
  • Kubyshkin Anatolij Vladimirovich
RU2805941C1
METHOD FOR DIFFERENTIAL DIAGNOSIS OF NODULAR FORMATIONS OF THE HUMAN THYROID GLAND 2021
  • Titov Sergej Evgenevich
  • Veryaskina Yuliya Andreevna
RU2757347C1
METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS OF THYROID GLAND 2023
  • Alnikin Aleksandr Borisovich
RU2820815C1
METHOD OF DETERMINING MANAGEMENT TACTICS FOR PATIENTS WITH THYROID NODULES 2022
  • Shcherbina Viktoriya Germanovna
RU2817505C2
METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULAR FORMATIONS OF THE THYROID GLAND 2021
  • Zima Dmitrij Vladimirovich
  • Bezrukov Oleg Filippovich
  • Zyablitskaya Evgeniya Yurevna
  • Golubinskaya Elena Petrovna
  • Makalish Tatyana Pavlovna
  • Maksimova Polina Evgenevna
  • Nepritimova Elena Andreevna
RU2783304C1
METHOD FOR PREOPERATIVE DIAGNOSIS OF MEDULLARY THYROID CANCER 2023
  • Titov Sergej Evgenevich
  • Lukyanov Sergej Anatolevich
  • Sergijko Sergej Vladimirovich
  • Veryaskina Yuliya Andreevna
RU2819521C1
METHOD OF ASSESSING THE RISK OF THYROID CANCER IN PATIENTS WITH NODULAR GOITER SYNDROME 2023
  • Petunina Nina Aleksandrovna
  • Donnikov Andrej Evgenevich
  • Rogova Marina Olegovna
  • Ippolitov Leonid Igorevich
  • Titov Sergej Evgenevich
  • Veryaskina Yuliya Andreevna
  • Martirosyan Narine Stepanovna
RU2814933C1
METHOD FOR ASSESSING THE RISK OF THYROID CANCER IN A PATIENT WITH NODULAR THYROID FORMATIONS 2019
  • Novosad Sofya Vladimirovna
  • Minushkina Larisa Olegovna
  • Petunina Nina Aleksandrovna
  • Martirosyan Narine Stepanovna
RU2725749C1

RU 2 823 767 C1

Authors

Romashchenko Pavel Nikolaevich

Maistrenko Nikolai Anatolevich

Krivolapov Denis Sergeevich

Simonova Mariia Sergeevna

Dates

2024-07-29Published

2023-04-19Filed